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Abstract 
Xenoestrogens such as phthalates, parabens, bisphenol A, 
dichlorodiphenyltrichloroethane, and dioxins are compounds found in ordinary 
substances such as detergents, cosmetics, plastics, pesticides and herbicides 
(Sonnenschein & Soto, 1998). Estrogen is a vital component in the development of the 
male and female reproductive system. However, xenoestrogens mimic endogenous 
estrogenic signaling and exhibit endocrine disrupting properties that may cause long-
lasting repercussions on human reproductive health. Xenoestrogen bind to both 
intracellular and membrane-bound estrogen receptors resulting in an inappropriate 
activation of tissue-specific estrogenic responses, leading to low sperm count in males 
and precocious puberty and polycystic ovarian syndrome in females (Shanle & Xu, 
2011). Although the pathways of many xenoestrogens mechanism are unknown, the 
detrimental outcomes on reproductive health are evident.  
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Impact of Xenoestrogens on Reproductive Health 
 
Introduction 
Xenoestrogens are endocrine disrupting chemicals that mimic estrogen in the 
human body. Exposure to xenoestrogens have far reaching repercussions on human 
reproductive health. Exposure to endocrine disrupting xenoestrogens alter the 
homeostasis of the reproductive system. This paper will discuss the predominant 
mechanisms of endocrine disruptors, the origins of xenoestrogens, the biological effects 
of xenoestrogens on the human reproductive system, and methods to minimize 
xenoestrogen exposure. Although a portion of the data incorporated in this paper will be 
collected from primary research articles with non-human subjects, the chief conclusions 
of this review will pertain to the human reproductive system (Takeuchi, Tsutsumi, 
Ikezuki, Takai, & Taketani, 2004). 
 17−estradiol (E2) is the chief endogenous estrogen hormone. Estrogens such as 
E2 are steroid hormones involved in a plethora of biological pathways such as the 
formation of androstenedione which consequently regulate the physiology of many tissue 
and organ functions including the development of both male and female reproductive 
organs. (Yasar, Ayaz, User, Gupur, & Muyan, 2016). The effects of estrogens are 
mediated through binding to the two estrogen receptors, estrogen receptor  (ER) and 
estrogen receptor  (ER) Estrogen receptors largely behave as ligand specific 
transcription factors. Xenoestrogens such as phthalates, bisphenol A (BPA), dioxins, 
dichlorodiphenyltrichloroethane (DDT), and parabens mimic endogenous estrogen by 
binding to ER and ER Like estrogen, xenoestrogens induce both genomic and non-
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genomic biological pathways. Repercussions of increased estrogen signaling through the 
presence of xenoestrogens compounds on human reproductive health include an 
increased frequency of precocious puberty and polycystic ovarian syndrome in females 
(PCOS) and decreased sperm count in males. 
Background and Significance 
Further research regarding the effects of xenoestrogens is crucial due to a direct 
correlation between the increased exposure to endocrine disrupting chemicals, the 
declined sperm count in males, and the increased frequency of precocious puberty and 
PCOS in females. Although general trends of the impact of xenoestrogens on 
reproductive health are manifest, the understanding of the xenoestrogen mechanism is 
insufficient (Jeung & Choi, 2010). Although there is a correlation between xenoestrogens 
and carcinogenesis this will be excluded for purpose of clear focus in this paper.  
Origins and Overview of Xenoestrogens 
Estrogenic mimicking compounds are found in daily products such as pesticides, 
industrial chemicals, cleaning products, and cosmetics (Sonnenschein & Soto, 1998). 
Endocrine disrupting chemicals are defined as environmental and or dietary compounds 
that interfere with endogenous hormone signaling, metabolism or synthesis (Shanle & 
Xu, 2011). Xenoestrogens that bind to ERs by exhibiting estrogenic structural similarities 
behave as endocrine disrupting compounds. Xenoestrogens alter biological functions 
through the following predominant methods: mimicking endogenous estrogen, disrupting 
synthesis and metabolism of endogenous estrogen and hormone receptors, and inhibiting 
the binding of endogenous estrogen (Sonnenschein & Soto, 1998). 
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 Endocrine disrupting chemicals such as phthalate esters are frequently found in 
plastics, detergents, solid waste disposal sites, and paints. Phthalates were first created in 
1920, serving as an alternative plasticizer for camphor. In 1970, phthalates were banned; 
however, their lasting effects are still prevalent (Wang et al., 2016). Studies have 
confirmed that phthalates such as dibutyl phthalate, di-2-ethylhexyl phthalate, dimethyl 
phthalate, monoethyl phthalate, mono-2-ethylhexyl phthalate, mono-benzyl phthalate, 
and monobutyl phthalate have direct correlation to the decrease in sperm concentration, 
motility, morphology, and DNA damage in humans (Wang et al., 2016).  
 Parabens such as methylparaben, ethylparaben, propylparaben, butylparaben, and 
isobutylparaben are compounds commonly found in beauty and personal care products 
such as shampoos, moisturizers, and face makeup. Parabens have anti-fungal and anti-
bacterial properties and serve as common preservatives. Parabens were first 
commercialized in the 1950’s and have continued to serve as preservatives in personal 
care products throughout the years (Scientific American, 2014).  
 BPA was first synthesized in 1891 by German chemists. In 1950, during the 
technology revolution, BPA production flourished alongside the growing plastic industry. 
In 1953, polycarbonate resins from BPA were invented by Dr. Hermann Schnell. 
Polycarbonate resins revolutionized the world of plastics, serving as a pliable yet durable 
compound. Polycarbonates served as plastic components of electronic applications, 
plastic bottles, and linings for metal-based cans. In the 1960’s the U.S. Food and Drug 
Administration (FDA) approved polycarbonate resins for packaging of food (Caliendo, 
2012). 
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 The estrogenic properties of BPA were not discovered until 1992 by Dr. David 
Feldman. The discovery arose while autoclaving containers formed from polycarbonates 
synthesized with BPA. The BPA leaching from the containers yielded estrogenic activity 
(Rissman, 2016). 
 The structure of BPA provides the ability to bind to both the ER and R 
receptor. As shown in Figure 1, the two (4,4’)-OH groups on the benzene rings allow 
BPA to bind to the ER. BPA is classified as an endocrine disrupting compound that binds 
to membrane-bound estrogen receptor inducing rapid non-genomic estrogenic signaling 
(Shanle & Xu, 2011). Since its commercialization, BPA serves as a model for 
xenoestrogen endocrine disrupting compounds. Industrially, BPA has been used as a 
monomer in the production of epoxy resins and polycarbonates. These compounds are 
common components of everyday products such as medical and dental devices, plastic 
water bottles, and thermal paper. Humans can absorb BPA through external or internal 
exposure. The highest exposure to BPA is attributed to food, resulting in part from plastic 
irrigation apparatuses (Acconcia, Pallottini, & Marino, 2015).   
The estrogen receptor affinity of BPA is notably lower than estradiol as shown in 
Figure 2. However, the circulating concentrations of BPA can match, or exceed, the 
circulating concentrations of estradiol. Humans can maintain an average of 1-2 ng/mL of 
BPA circulating in serum and such concentrations are elevated enough to classify as a 
biologically active level (Nagel & Bromfield, 2013). Such levels of circulating BPA have 
been linked to a variety of reproductive-targeted pathologies such as infertility and 
recurrent pregnancy loss (Acconcia et al., 2015).   
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Figure 1. Chemical structure comparison between 17 -estradiol and Bisphenol A. The 
ability of BPA to mimic estradiol derives structural similarities between the two phenol 
groups of BPA and E2 (Steinmetz, Brown, Allen, Bigsby, & Ben-Jonathan, 1997). BPA 
surpasses the minimum chemical structural requirements for estrogenic activity of a 4-
OH group on the A-phenyl ring and a hydrophobic side group on the 2-position of the 
propane. The two (4,4’)-OH groups on the benzene rings allows BPA to bind to the ER.  
Adapted from ACD/Structure Elucidator, C40E41, Advanced Chemistry Development, 
Inc., 2017. Used by permission.  
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Figure 2. Dose response curve of BPA versus E2. This dose response curve depicts BPA 
eliciting an estrogenic response at high concentrations. This graph displays the 
comparable binding trends of BPA to estrogen, supporting the estrogenic properties of 
BPA. Used by permission from Dr. Cameron Q. Sheeler, Liberty University. 
 
BPA disrupts the endocrine balance in the following three ways: estrogen 
mimicking, antiandrogen behavior, and steroid hormone synthesis alteration. First, BPA 
behaves as a xenoestrogen and binds to estrogen receptors causing estrogen-like 
behaviors. Additionally, BPA behaves as an antiandrogen; blocking the standard action 
of androgens. Through scientific studies of Acconcia, Pallottini and Marino (2015) 
evaluating the antiandrogen behavior of BPA through transcriptional activation and 
androgen receptor redistribution assay, it is known that BPA binds to androgen receptors, 
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blocking nuclear translocation. BPA binds to androgen receptors in a manner that inhibits 
the efficient transfer of the androgen receptor into the nucleus. When BPA is present, a 
higher concentration of androgen receptors is required and or require a longer amount of 
time for the translocation process to occur. Consequently, in the presence of BPA, 
androgen receptor translocation is drastically delayed. Lastly, BPA has ability to alter the 
synthesis of steroid hormones (Acconcia et al., 2015).  BPA alters progesterone and 
estradiol synthesis in vitro and reduces mRNA and protein expression levels of three 
genes encoding steroidogenesis enzymes. 
Dichlorodiphenyltrichloroethane (DDT) was once employed as a pesticide in 
agricultural communities. DDT was first created in the United States during the 1940’s. It 
quickly dominated the insecticide community due to its ability to combat insect-borne 
human diseases such as malaria and typhus. In 1972, the use of DDT was banned in the 
United States due to its adverse environmental effects (United States Environmental 
Protection Agency, 2017). 
 DDT functions as an endocrine disrupting chemical through the following two 
mechanisms: competing with endogenous estrogen for receptor binding sites and 
stimulating the release of gonadotropin-releasing hormone (GnRH). Both functions cause 
a notable disturbance to the homeostatic status of the human endocrine system. Due to 
the stimulation of GnRH release, the presence of DDT can induce premature female 
puberty. While DDT has not been shown to affect the male puberty process, exposure to 
DDT post-puberty is linked to low semen quality (Nabi, Muhammad, Khan, & Ali, 
2015).   
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Dioxin behaves as another endocrine disrupting compound. Dioxins were first 
produced in Germany in the 1800’s. In the early 1900’s dioxins were widely used in 
electrical transformer cooling fluids, lubricants, and plastics. Due to the toxic properties 
of dioxins, the United States Congress banned the use of dioxins in 1978. However, 
dioxins are deemed a persistent environmental pollutant. Although widespread 
throughout the environment, dioxins are commonly found in the food chain, specifically 
the fatty tissue of animals. These harmful chemicals are both byproducts of a variety of 
industrial processes such as chlorine bleaching and pesticide synthesis as well as natural 
processes such as forest fires and volcanic eruptions (“Dioxins and Their Effect,” 2016). 
Exposure to low concentrations of 2,3,7,8-tetrachlorodibenzo-p-dioxin is associated with 
the premature maturation of the genitals, gonads, and hypothalamic-pituitary axis (Nabi 
et al., 2015). 
Mechanism of Endocrine Disruptors 
Xenoestrogens are classified as endocrine disrupting chemicals. The presence of 
xenoestrogens may cause dysregulation of the estrogen receptor dependent transcriptional 
pathways resulting in the false induction of tissue-specific estrogenic responses (Ozen & 
Darcan, 2011). The inappropriate signaling resulting from xenoestrogen-estrogen receptor 
binding can lead to the overall degradation of reproductive health, consequently altering 
fertility (Shanle & Xu, 2011). 
ER and ER serve as the two subtypes of nuclear estrogen receptors in humans 
that mediate the effects of normal estrogen signaling in both reproductive and non-
reproductive tissue (Shanle & Xu, 2011). Estrogen receptor subtype expressions show 
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specificity to tissue types. In females, ER is highly expressed in reproductive tissues 
such as the ovaries, uterus, and mammary glands. ER is minimally expressed in the 
mammary glands while significantly expressed in the ovaries. In males, ER is highly 
expressed in the prostate, epididymis, and germinal cells (Lecomte, Demay, Ferriere, & 
Pakdel, 2017).  
ER and ER function as ligand-dependent transcriptional factors; however, 
ER and ER exhibit differing ligand specificities and transcriptional activities (Hess et 
al., 1997). The function of ER and ER is dependent on cofactor availability and 
cellular context (Shanle & Xu, 2011).  
 ER and ER are located respectively on chromosome 6 ESR1 and chromosome 
14 ESR2 (Rochira et al., 2016). As denoted in Figure 3, ER is comprised of 595 amino 
acids and includes eight exons, resulting in a total length of 66kDa proteins. The genomic 
segment of ER spans approximately 300kb. ER is comprised of eight exons and 530 
amino acids, spanning 254kb. The central domain of the estrogen receptors contains a 
conserved zinc finger DNA-binding domain (Yasar et al., 2016). The ligand-independent 
transactivation function is located on the N-terminal domain of the estrogen receptor 
while the ligand-dependent transactivation function is located on the C-terminal domain 
(Lecomte et al., 2017). The DNA binding domains exhibit a 97% similarity between both 
ER and ER while the N-terminal and C-terminal exhibits a 17% and 56% similarity, 
respectively (Yasar et al., 2016).  
Xenoestrogens with endocrine disrupting activities must bind to intracellular or 
membrane-bound estrogen receptors, activating a hormonal transduction system  
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Figure 3. ER and ER are composed of 595 and 530 amino acids, respectively. Both 
ER and ER are comprised of 8 exons. The N-terminal of ER and ER share an amino 
acid similarity of 17% while the DNA binding region of central C exhibit a shared 
identity of 97% of amino acids. Upon binding of E2, ER and ER dimerizes which 
causes a conformational change resulting in a functionally active estrogen receptor. 
Adapted from “Molecular mechanism of estrogen-estrogen receptor signaling.” By P. 
Yasar, G. Ayaz, S. D. User, G. Gupur, and M. Muyan, 2017, Reproductive Medicine and 
Biology, 16, p. 5. Copyright 2016 by Reproductive Medicine and Biology. Used by 
permission.  
 
(Welshons et al., 2003). Typically, xenoestrogens bind to intracellular estrogen receptors 
acting on the genomic level. However, ER targeting xenoestrogens exhibit the potential to 
alter both genomic and non-genomic estrogen receptor activity. Genomic altering 
xenoestrogens include phytoestrogens, bisphenols, and organochlorine pesticides (Shanle 
& Xu, 2011). 
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As shown in Figures 4 and 5, genomic signaling results from ligands binding to 
intracellular ER causing dimerization. Sequentially, ER dimers coupled with other 
transcriptional factors directly bind to DNA, initiating a genomic transcription. The 
intracellular ligand-dependent receptor process is contrasted with the non-genomic 
process. The non-genomic process results from a ligand binding to membrane-bound 
ERs, triggering a cellular cascade (Nadal et al., 2000). When ligands bind to membrane 
bound ERs a rapid response to estrogenic exposure occurs (Shanle & Xu, 2011). As 
depicted in Figure 5, the activity of membrane bound ERs is mediated through a G-
protein coupled receptor. This G-coupled protein receptor, known as GPR30, activates 
MAPK or P13 kinase signaling cascade.  
Another method of endocrine disrupting chemicals is through binding site 
competition. Ligands bind to receptor sites through the amino acid side groups that 
provide hydrophilic interactions or hydrogen bonding between ligand and receptor. 
ER and ER contain large binding sites which allow the binding of a variety of small 
molecules. The presence of high concentrations of endocrine disrupting chemicals with 
affinity for ER and ER ligand binding sites minimizes the chance of the proper binding 
of endogenous estrogen. An inappropriate activation of estrogen receptors results through 
the binding of endocrine disrupting chemicals such as BPA (Shanle & Xu, 2011). 
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Figure 4. Genomic versus non-genomic estrogen receptor signaling pathway. Genomic 
signaling occurs when ligands, including xenoestrogens, diffuse across the cellular 
phospholipid bilayer binding directly to the intracellular ER causing ER dimerization. 
Dimerized ERs bind directly to the estrogen response element. Non-genomic signaling 
occurs when ligands bind membrane-bound estrogen receptors resulting in activation of 
kinase signaling cascade. Adapted from “Endocrine disrupting chemicals targeting 
estrogen receptor signaling: identification and mechanisms of action.” By E. K. Shanle, 
and W. Xu, 2011, Chemical Research in Toxicology, 14, p. 27. Used by permission.  
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Figure 5. Integrated model of the activation of the kinase cascade leading to the cellular 
response. The ER bound with E2 interacts with the G protein that activates kinases. The 
kinases then phosphorylate regulatory proteins and transcriptional proteins leading to 
alterations in gene expression. Adapted from “Molecular mechanism of estrogen-estrogen 
receptor signaling.” By P. Yasar, G. Ayaz, S. D. User, G. Gupur, and M. Muyan, 2017, 
Reproductive Medicine and Biology, 16, p. 9. Copyright 2016 by Reproductive Medicine 
and Biology. Used by permission.  
IMPACT OF XENOESTROGENS ON REPRODUCTIVE HEALTH 
 
17 
Function of Endogenous Estrogen in the Female Reproductive System 
Estrogen is an endogenous hormone that is vital in both males and females. 
Estrogen regulates the development of secondary sexual characteristics such as the 
regulation of menstrual cycle, stimulation of endometrium growth, and breast 
development. In males, estrogen functions as a component in sperm maturation. Estrogen 
serves as a feminizing factor during fetal development.  
In female humans, endogenous estrogen is chiefly produced in the ovaries, 
placenta, and adrenal glands. Through the action of androgenase, androgen, the estrogen 
precursor, is converted to estrogen. The ovaries serve as the main site of estrogen 
synthesis due to their high content of aromatase (Knudtson & McLaughlin, n.d.). 
Estrogen is a primary regulator in the growth and development of the mammary 
glands, vagina, fallopian tubes, uterus, egg follicle, and endometrial lining.  
Estrogen circulates the bloodstream, targeting organs such as the breasts, vagina, and 
uterus. As shown in Figure 6, puberty is initiated through the elevation of luteinizing 
hormone (LH) and follicle-stimulating hormone (FSH) levels. This occurs as a result of 
the release of GnRH by the hypothalamus. The increased release of GnRH results in LH 
and FSH secretion. These high levels of LH and FSH promote the production of estrogen. 
Elevated estrogen levels then result in the development of secondary sexual 
characteristics (Knudtson & McLaughlin, n.d.) 
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Figure 6. Endocrinology of female reproductive system development. The hypothalamus 
secretes gonadotropin-releasing hormone (GnRH) which regulates the release of the 
luteinizing hormone (LH) and follicle-stimulating hormone (FSH) from the anterior 
pituitary gland. The ovaries are stimulated by LH and FSH and estrogen is synthesized. 
Adapted from, “Hormonal Regulation of the Female Reproductive System.” 2017. Open 
University. Used by permission.  
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Effects of Xenoestrogens on the Female Reproductive System 
Estrogen stimulates the generation of secondary female sexual characteristics 
such as endometrial growth, menstrual cycle regulation, and breast development.  
Puberty is characterized by the maturation of the hypothalamic pituitary gonadal axis in 
addition to the development of secondary sexual features. The age at which puberty 
occurs in females is growing progressively younger (Ozen & Darcan, 2001). Negative 
health implications such as a predisposition to polycystic ovarian syndrome arises from 
precocious puberty. The onset of puberty is regulated by the endocrine system and 
exposure to xenoestrogens may have a dysregulating impact upon the hypothalamic-
pituitary-gonadal system (Massart et al., 2006).  
Endocrine disruptors such as phytoestrogens and phthalates have been identified 
as possible environmental factors influencing the onset of female puberty (Nabi et al., 
2015). Xenoestrogens directly influence the gonadotropin-releasing hormone resulting in 
an increased endogenous estrogen production. Studies show that some xenoestrogens 
cause premature puberty due to an activation of increased GnRH production. The release 
of the GnRH from the hypothalamus causes the secretion of the follicle stimulating 
hormone and luteinizing hormone which cause the progression of puberty. The 
modification of normal GnRH release through the interference with xenoestrogens 
directly impacts the progress of puberty (Ozen & Darcan, 2011).  
These endocrine disrupting chemicals exert their estrogenic characteristics 
through direct binding to intracellular or extracellular estrogen receptors or increasing 
aromatase activity. Aromatase is an enzyme catalyst that increases the conversion of 
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testosterone into estrogen. These behaviors increase the total amount of estrogen-
behaving compounds present (Ozen & Darcan, 2011).    
The female gonad exhibits heightened sensitivity to exposure to BPA. Endocrine 
disrupting compounds such as BPA interfere with ovarian morphology, steroidogenesis, 
and folliculogenesis. BPA, commonly found in ovarian follicular fluid, exhibits a 
stimulatory role in ovarian theca-interstitial cells. These cells are responsible for the 
production of androgens through the direct regulation of 17-hydroxylase. This 
hydroxylase is a vital enzyme in androgen synthesis. Consequently, the presence of BPA 
stimulates the production of androgen synthesis. Heightened androgen synthesis is a 
characteristic of polycystic ovarian syndrome (Barrett & Sobolewski, 2014).  
 There is a strong correlation between polycystic ovarian syndrome (PCOS) and 
BPA exposure. PCOS is defined by anovulation and hyperandrogenemia (Barrett & 
Soboleweski, 2014). PCOS is responsible for 80% of anovulatory infertility cases (Melo, 
Ferriani & Navarro, 2015). Scientific studies evaluating the BPA-serum levels of women 
suffering from PCOS exhibited high levels of BPA compared to non-hyperandrogenemia 
women (Takeuchi et al., 2004).  
Effects of Estrogen on Male Reproductive Development  
While testosterone serves as the hormone responsible for the development of 
secondary male sexual characteristics, estrogen is a vital component of sperm maturation 
and vitality. Blood-estrogen concentration in males is low; however, estrogen content in 
semen and rete teste fluid is extraordinarily high, reaching up to 250 pg ml-1 (Ruz et al., 
2006). The two primary estrogen receptors, ER and ER, are present in the testes 
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(Joseph et al., 2011). ER is expressed in fetal testes, suggesting a role of estrogen in the 
maturation of testes (Rochira et al., 2016). Secondly, ER is expressed in the efferent 
ductules regulating fluid reabsorption (Joseph et al., 2011).  
Appropriate fluid regulation is an essential component in the male reproductive 
system. The efferent ductules located in the testes serve as the primary site of fluid 
reabsorption. ER serves as a fluid reabsorption regulator in the efferent ductules. Fluid 
regulation includes the dictation of ion transport and water reabsorption (Joseph et al., 
2011).  
Effects of Xenoestrogens on the Male Reproductive System 
The detrimental effect of xenoestrogens on the male reproductive system is 
chiefly via the manifestation of embryonic exposure to xenoestrogens. Such exposures 
impact specific structures of the male reproductive system; ultimately, negatively 
influencing future fertility (Rochira et al., 2016). Sperm counts in Western countries have 
declined 50% since 1966. Sperm counts are also reported to have decreased from 113 
million/mL to 66.5 million/mL from 1940 to 1990 (Giwercman, Carlsen, Keiding, & 
Skakkebaek, 1993). This trend in decreasing sperm count has been partially credited to 
the increase of endocrine disrupting xenoestrogens (Wang et al., 2016).  
 The impact of xenoestrogens on male fertility was first observed in wild animals 
including fish, amphibians, mammals, reptiles, and birds that had exposure to estrogenic 
chemicals in their natural environment. Alterations in male reproductive habits and the 
general feminization in reproductive behavior have been noted in such wild animals 
(Delbes, Levacher, & Habert, 2006). 
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Neonatal tests have proven to be highly sensitive to xenoestrogens. High exposure 
to xenoestrogens correlates with the inactivation of ER and ER (Delbes et al., 2006). 
Inactivation of ER and ER poses a serious threat to male fertility. Decreased fluid 
reabsorption results in a backflow of fluid from the efferent ductules into the testes; 
causing decreased sperm concentration and motility (Ruz et al., 2006). In addition to the 
backflow of fluid into the testes, disruption of fluid levels results in diluted sperm 
entering the epididymis decreasing sperm count in semen and ultimately decreasing 
fertility (Hess et al., 1997). The ER role in fluid reabsorption has been tested through 
mice with an ER knockout gene. Mice deficient of the estrogen receptor ER were 
sterile due to the elevated fluid retention in the efferent ductules (Hess et al., 1997). 
The absence, or diminished, levels of R are also linked to long-term teste 
atrophy. Decreased fluid reabsorption stems from the lack of an epithelial cell component 
responsible for the uptake of fluids. Such structures are the endocytic vesicles and PAS+ 
lysosomal granules of the epithelial cell. The backpressure resulting from luminal fluids 
causes long-term atrophy of the testes (Hess et al., 1997).  
Minimizing Xenoestrogen Exposure 
The presence of endocrine disrupting chemicals in everyday household products 
should not be minimized or dismissed. Xenoestrogens such as phthalates, BPA, and 
parabens are found in perfumes, plastic containers, and cosmetics, respectively. Measures 
can be taken to minimize the presence of xenoestrogen in one’s environment. Plastic 
containers such as reusable plastic water bottles and food storage containers commonly 
contain BPA products. Reheating food in plastic containers allows for heightened 
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amounts of xenoestrogens to leach out and penetrate food. Avoiding consuming products 
stored in plastics can be accomplished through drinking water from stainless steel water 
bottles and alternatively using glass containers as a replacement for plasticware.  
 Cosmetic products and perfumes commonly contain endocrine disrupting 
compounds such as phthalates. Phthalates can be found in personal care products items 
including soaps, perfumes, nail polish removal, diaper cream, wet wipes, face paint, baby 
powder, glitter gel, and baby oil (U.S. Food & Drug Administration [FDA], 2013).  
The most predominant phthalate compounds historically found in personal care products 
are dibutylpthalate, dimethlpthalate, and diethylphthalate. Today, diethylphthalate is the 
primary phthalate still found in cosmetics (FDA, 2013). Exposure to phthalates can be 
accomplished through the following mechanisms: ingestion, inhalation, integumentary 
absorption, and intravenous injection. Industries use phthalates for solvent and fixative 
properties of the compounds (Al-Saleh & Elkhatib, 2016). The FDA (2013) advises the 
primary method of avoiding phthalates exposure from personal care products is to 
consciously seek and buy non-phthalate containing products.  
Parabens are compounds found in a wide variety of cosmetics such as shampoos, 
moisturizers, shaving products, and deodorants. Parabens serve as anti-bacterial 
compounds that prevent unwanted bacterial presence in personal care products. Despite 
the beneficial presence of parabens regarding limiting bacterial growth, parabens exhibit 
endocrine disrupting qualities. Exposure to parabens through personal care products can 
be circumvented by prudently reading product labels. If a product contains parabens, the 
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ingredient list would contain compound names such as methylparaben, propylparaben, 
butylparaben, or ethylparaben (FDA, 2018).  
Conclusion  
Xenoestrogens are endocrine disrupting chemicals that mimic endogenous 
estrogen in the human body. Chemicals such as PBA, parabens, phthalates, dioxins, and 
dichlorodiphenyltrichloroethane are compounds found in pesticides, plastic containers, 
and personal care products (Sonnenschein & Soto, 1998). Through mimicking estrogen, 
xenoestrogens inappropriately trigger estrogen receptors. Xenoestrogens exhibit the 
capabilities to trigger both genomic and non-genomic pathways through binding to 
intracellular estrogen receptors and membrane-bound receptors, respectively. 
 Xenoestrogens alter biological functions through mimicking endogenous 
estrogens, disrupting synthesis and metabolism of endogenous estrogen and hormone 
receptors, and inhibiting the binding of endogenous estrogen (Sonnenschein & Soto, 
1998). Exposure to such compounds have far reaching repercussions on human 
reproductive health such as decreased sperm count, precocious puberty, and polycystic 
ovarian syndrome. Xenoestrogen exposure can be minimized through implementing 
lifestyle changes such as avoiding heating food in reusable plasticware and switching to 
paraben-free health and beauty products.   
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